Healthcare and Life Sciences

Contact Us

Duff & Phelps Healthcare and Life Sciences team provides Fortune 500 corporations, middle-market and growth companies and financial sponsors access to our valuation and corporate finance services.

Our dedicated team completes nearly 200 healthcare engagements annually, including engagements in healthcare services, Pharmaceuticals, Medical Technology and Life Sciences. As a firm, Duff & Phelps stands alone in our objectivity, deep technical and industry expertise and breadth of advisory services.

/industries/healthcare-and-life-sciences /-/media/feature/industries/desktop/health-life-sciences.jpg industry {D59CA77E-C551-45A3-BE89-F567210C5A60} {DC6234F2-03B5-4F3D-9CDE-146A80B170AD} {6B6F3B01-98A6-4BC2-B2CD-CBD127447FB5} {5CE144D0-ADDC-43A3-95E4-3428CA819BF8} {D3AE3EC6-3254-4441-B111-1AF8D558906C} {13E28841-C245-441D-8C3B-49E72DA5381C} {C8894F56-FF6C-4DEA-AB91-58D66A7F0624} {B062D54C-1425-4A04-8F9F-95EA14068E6D} {2746A2DD-363F-4E48-8914-B4F0BDEA669C}

Other Areas We Can Help

Corporate Finance

Comprehensive support throughout mergers and acquisitions and other corporate transactions.

Corporate Finance

Healthcare M&A

Healthcare expertise for middle-market M&A transactions.

Healthcare M&A
Transaction Advisory Services

Transaction Advisory Services

Seamless analytical advisory through the deal continuum, from transaction origination to closing.

Transaction Advisory Services

Financial Sponsors Group

Dedicated coverage and access to M&A deal-flow for financial sponsors.

Financial Sponsors Group

Governance and Risk Advisory

Combined Duff & Phelps and Kroll disputes, investigations, cyber, business intelligence, restructuring and other advisory.

Governance and Risk Advisory

Valuation Advisory

Valuation and consulting for financial reporting; federal, state and local tax; investment; and risk management purposes.

Valuation Advisory

Tax Services

Property tax, site selection, transfer pricing, sales and use tax and unclaimed property advisory.

Tax Services

Case Studies

Insights

Valuation

Emerging Uncertainties by Professor Andrea Boltho

Valuation
M&A Advisory

Healthcare Services Sector Update – Autumn 2021

M&A Advisory
Valuation

LNG Market Outlook Brief and Key Take-aways in a Fast-changing Environment

Valuation
M&A Advisory

European Chemicals Update – Q3 2021

M&A Advisory

News